pubmed-article:11213596 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C1710263 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0028754 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0221155 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0221099 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0596620 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C0205189 | lld:lifeskim |
pubmed-article:11213596 | lifeskim:mentions | umls-concept:C1709701 | lld:lifeskim |
pubmed-article:11213596 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:11213596 | pubmed:dateCreated | 2001-2-13 | lld:pubmed |
pubmed-article:11213596 | pubmed:abstractText | To assess the prevalence of borderline isolated systolic hypertension (borderline ISH), and to examine its association with other cardiovascular risk factors. | lld:pubmed |
pubmed-article:11213596 | pubmed:language | eng | lld:pubmed |
pubmed-article:11213596 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11213596 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11213596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11213596 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11213596 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11213596 | pubmed:month | Feb | lld:pubmed |
pubmed-article:11213596 | pubmed:issn | 1462-8902 | lld:pubmed |
pubmed-article:11213596 | pubmed:author | pubmed-author:MelanderAA | lld:pubmed |
pubmed-article:11213596 | pubmed:author | pubmed-author:RåstamLL | lld:pubmed |
pubmed-article:11213596 | pubmed:author | pubmed-author:RanstamJJ | lld:pubmed |
pubmed-article:11213596 | pubmed:author | pubmed-author:LindbladUU | lld:pubmed |
pubmed-article:11213596 | pubmed:author | pubmed-author:Bøg-HansenEE | lld:pubmed |
pubmed-article:11213596 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11213596 | pubmed:volume | 3 | lld:pubmed |
pubmed-article:11213596 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11213596 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11213596 | pubmed:pagination | 25-31 | lld:pubmed |
pubmed-article:11213596 | pubmed:dateRevised | 2009-11-3 | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:meshHeading | pubmed-meshheading:11213596... | lld:pubmed |
pubmed-article:11213596 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11213596 | pubmed:articleTitle | Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project. | lld:pubmed |
pubmed-article:11213596 | pubmed:affiliation | Department of Community Medicine, Malmö University Hospital, Malmö, Sweden. fou-enheten.skara@swipnet.se | lld:pubmed |
pubmed-article:11213596 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11213596 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |